THE IMPACT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TAMADON M.R.; KHATIBINEZHAD A.; GHORBANI R.; SOLEIMANI ALIREZA; MALEK F.; JALALZADEH M.; MALEK MOJTABA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Nephro-Urology Monthly Year:2011 | Volume:3 | Issue:2 Page(s): 114-117

Download Full-Text

View:

275

Download:

Cites:

Information Journal Paper

Title

THE IMPACT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Author(s)

Keywords

ERYTHROPOIETIN

CHRONIC KIDNEY FAILURE

CREATININE

Abstract

Background: Chronic kidney disease (CKD) is a worldwide health problem. But despite to new routes of dialysis, mortality and morbidity is high. One of the most common symptom of CKD is anemia, especially is more obvious in stages 3 and 4. Objectives: In this study, the effects of ERYTHROPOIETIN on renal function were assessed by meas urement of serum CREATININE level. Patients and Methods: Twenty three adult patients with CKD in the stages 3 and 4, enrolled in study and serum CREATININE level was monthly measured three months before need to pre scribe the ERYTHROPOIETIN due to anemia resulting from CKD (hemoglobin less than 12g/dl) and continued 6 months after administration of the drug. Based on patients' needs, the drug was administered subcutaneously in a dose of 4000-6000 units per week so patients' hemoglobin level became more than 12g/dL. During the study, all patients who required to dialysis or kid ney transplantation were excluded from the study.Results: Mean of CREATININE and 1/creatinine values in 4 states including three-month before intervention, time to intervention, and the three months after the intervention and the six month after the intervention were 2.17 and 0.50; 2.45 and 0.45; 2.41 and 0.47; 2.30 and 0.49 respectively which were not statistically significant. Conclusion: The administration of recombinant human ERYTHROPOIETIN in stage 3 and 4 of chronic kidney disease, improves anemia with no impact on renal function.

Cites

No record.

References

No record.

Cite

APA: Copy

TAMADON, M.R., KHATIBINEZHAD, A., GHORBANI, R., SOLEIMANI, ALIREZA, MALEK, F., JALALZADEH, M., & MALEK, MOJTABA. (2011). THE IMPACT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, 3(2), 114-117. SID. https://sid.ir/paper/323663/en

Vancouver: Copy

TAMADON M.R., KHATIBINEZHAD A., GHORBANI R., SOLEIMANI ALIREZA, MALEK F., JALALZADEH M., MALEK MOJTABA. THE IMPACT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY[Internet]. 2011;3(2):114-117. Available from: https://sid.ir/paper/323663/en

IEEE: Copy

M.R. TAMADON, A. KHATIBINEZHAD, R. GHORBANI, ALIREZA SOLEIMANI, F. MALEK, M. JALALZADEH, and MOJTABA MALEK, “THE IMPACT OF HUMAN RECOMBINANT ERYTHROPOIETIN ON RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE,” THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, vol. 3, no. 2, pp. 114–117, 2011, [Online]. Available: https://sid.ir/paper/323663/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops